These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23383065)

  • 1. TLR-9 contributes to the antiviral innate immune sensing of rodent parvoviruses MVMp and H-1PV by normal human immune cells.
    Raykov Z; Grekova SP; Hörlein R; Leuchs B; Giese T; Giese NA; Rommelaere J; Zawatzky R; Daeffler L
    PLoS One; 2013; 8(1):e55086. PubMed ID: 23383065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of an antiviral response in normal but not transformed mouse cells: a new determinant of minute virus of mice oncotropism.
    Grekova S; Zawatzky R; Hörlein R; Cziepluch C; Mincberg M; Davis C; Rommelaere J; Daeffler L
    J Virol; 2010 Jan; 84(1):516-31. PubMed ID: 19864388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic Rodent Protoparvoviruses Evade a TLR- and RLR-Independent Antiviral Response in Transformed Cells.
    Angelova A; Pierrard K; Detje CN; Santiago E; Grewenig A; Nüesch JPF; Kalinke U; Ungerechts G; Rommelaere J; Daeffler L
    Pathogens; 2023 Apr; 12(4):. PubMed ID: 37111493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parvovirus evades interferon-dependent viral control in primary mouse embryonic fibroblasts.
    Mattei LM; Cotmore SF; Tattersall P; Iwasaki A
    Virology; 2013 Jul; 442(1):20-7. PubMed ID: 23676303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translation control by protein kinase R restricts minute virus of mice infection: role in parvovirus oncolysis.
    Ventoso I; Berlanga JJ; Almendral JM
    J Virol; 2010 May; 84(10):5043-51. PubMed ID: 20219905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune cells participate in the oncosuppressive activity of parvovirus H-1PV and are activated as a result of their abortive infection with this agent.
    Grekova S; Aprahamian M; Giese N; Schmitt S; Giese T; Falk CS; Daeffler L; Cziepluch C; Rommelaere J; Raykov Z
    Cancer Biol Ther; 2010 Dec; 10(12):1280-9. PubMed ID: 21124075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 plays a role in minute virus of mice infection.
    Garcin PO; Nabi IR; Panté N
    Virology; 2015 Jul; 481():63-72. PubMed ID: 25768892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autonomous parvoviruses neither stimulate nor are inhibited by the type I interferon response in human normal or cancer cells.
    Paglino JC; Andres W; van den Pol AN
    J Virol; 2014 May; 88(9):4932-42. PubMed ID: 24554651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial reversion of conditional transformation correlates with a decrease in the sensitivity of rat cells to killing by the parvovirus minute virus of mice but not in their capacity for virus production: effect of a temperature-sensitive v-src oncogene.
    Salome N; van Hille B; Geuskens M; Rommelaere J
    J Virol; 1989 Nov; 63(11):4797-807. PubMed ID: 2507792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome replication and postencapsidation functions mapping to the nonstructural gene restrict the host range of a murine parvovirus in human cells.
    Rubio MP; Guerra S; Almendral JM
    J Virol; 2001 Dec; 75(23):11573-82. PubMed ID: 11689639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of a glioma-specific immune response by oncolytic parvovirus Minute Virus of Mice infection.
    Grekova SP; Raykov Z; Zawatzky R; Rommelaere J; Koch U
    Cancer Gene Ther; 2012 Jul; 19(7):468-75. PubMed ID: 22539062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic murine autonomous parvovirus, a candidate vector for glioma gene therapy, is innocuous to normal and immunocompetent mouse glial cells.
    Abschuetz A; Kehl T; Geibig R; Leuchs B; Rommelaere J; Régnier-Vigouroux A
    Cell Tissue Res; 2006 Sep; 325(3):423-36. PubMed ID: 16699801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Retrotransposons and the Global Shutdown of Homeostatic Innate Immunity by Oncolytic Parvovirus H-1PV in Pancreatic Cancer.
    Neulinger-Muñoz M; Schaack D; Grekova SP; Bauer AS; Giese T; Salg GA; Espinet E; Leuchs B; Heller A; Nüesch JPF; Schenk M; Volkmar M; Giese NA
    Viruses; 2021 May; 13(6):. PubMed ID: 34071585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric and pseudotyped parvoviruses minimize the contamination of recombinant stocks with replication-competent viruses and identify a DNA sequence that restricts parvovirus H-1 in mouse cells.
    Wrzesinski C; Tesfay L; Salomé N; Jauniaux JC; Rommelaere J; Cornelis J; Dinsart C
    J Virol; 2003 Mar; 77(6):3851-8. PubMed ID: 12610161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell migration is another player of the minute virus of mice infection.
    Garcin PO; Panté N
    Virology; 2014 Nov; 468-470():150-159. PubMed ID: 25173091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of promoter P4 of the autonomous parvovirus minute virus of mice at early S phase is required for productive infection.
    Deleu L; Pujol A; Faisst S; Rommelaere J
    J Virol; 1999 May; 73(5):3877-85. PubMed ID: 10196282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral immune responses against minute virus of mice vectors.
    Lang SI; Giese NA; Rommelaere J; Dinsart C; Cornelis JJ
    J Gene Med; 2006 Sep; 8(9):1141-50. PubMed ID: 16800041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization of transformed rat fibroblasts to killing by parvovirus minute virus of mice correlates with an increase in viral gene expression.
    Cornelis JJ; Spruyt N; Spegelaere P; Guetta E; Darawshi T; Cotmore SF; Tal J; Rommelaere J
    J Virol; 1988 Sep; 62(9):3438-44. PubMed ID: 3404581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Plasmacytoid and Monocyte-Derived Dendritic Cells Display Distinct Metabolic Profile Upon RIG-I Activation.
    Fekete T; Sütö MI; Bencze D; Mázló A; Szabo A; Biro T; Bacsi A; Pazmandi K
    Front Immunol; 2018; 9():3070. PubMed ID: 30622542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virulent variants emerging in mice infected with the apathogenic prototype strain of the parvovirus minute virus of mice exhibit a capsid with low avidity for a primary receptor.
    Rubio MP; López-Bueno A; Almendral JM
    J Virol; 2005 Sep; 79(17):11280-90. PubMed ID: 16103180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.